儿童的侵袭性真菌感染 - - 取得了进展还是仍存在障碍?
Daniel K Yeoh1, Coen Butters2, Julia E Clark3
1Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
概括
免疫受损儿童的侵入性真菌感染 (IMI) 的结果不好. 诊断和新型抗真菌药物的进步提供了希望,但需要更多的儿科数据才能有效实施.
科学领域:
- 儿童传染病 儿童传染病
- 医学真菌学 医学真菌学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 侵入性真菌感染 (IMI) 是免疫功能低下儿童疾病和死亡的重要原因.
- 目前儿童IMI的诊断工具和治疗方法存在局限性,导致患者的治疗结果不佳.
研究的目的:
- 审查目前和新兴的方法来诊断和治疗免疫受损儿童的IMI.
- 专注于儿科IMI管理的最新进展和持续挑战.
主要方法:
- 在PubMed的综合文献搜索中,寻找儿科IMI的诊断和管理工具.
- 包括临床研究,临床前研究,共识指南和评论.
主要成果:
- 像CT扫描这样的诊断成像缺乏特异性;分子分析和生物标志物显示出希望,但需要更多的儿科数据.
- 新型抗真菌药物 (例如,伊萨夫康纳) 和免疫疗法正在出现,但仍需要特定的儿科临床试验数据.
- 像培养和组织学这样的传统方法仍然至关重要,但在灵敏度和周转时间方面存在局限性.
结论:
- 通过新的诊断技术,抗真菌药物和免疫疗法,在IMI管理方面取得了重大进展.
- 进一步的儿科研究至关重要,以指导这些进展在治疗侵入性菌感染方面的最佳临床应用.
相关概念视频
Infection
11.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Fungal Phylum Microsporidia
387
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
387
Fungal Group Zygomycota
958
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
958
Cystic Fibrosis: Management
447
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
447
Cystic Fibrosis: Pathogenesis
680
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
680
Transmission-based Precautions II: Airborne and Protective Environment
1.8K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K


